No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr2:113875400-113887400 |
Weak transcription |
Spleen |
Spleen
|
2 |
chr2:113876000-113887400 |
Weak transcription |
Gastric |
stomach
|
3 |
chr2:113876000-113896200 |
Weak transcription |
Rectal Mucosa Donor 31 |
rectum
|
4 |
chr2:113876600-113885000 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
5 |
chr2:113879800-113885200 |
Weak transcription |
Esophagus |
oesophagus
|
6 |
chr2:113880400-113882200 |
Enhancers |
HepG2 |
liver
|
7 |
chr2:113880800-113882000 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
8 |
chr2:113880800-113882200 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
9 |
chr2:113880800-113882800 |
Enhancers |
Primary Natural Killer cells fromperipheralblood |
blood
|
10 |
chr2:113880800-113882800 |
Flanking Active TSS |
Monocytes-CD14+_RO01746 |
blood
|
11 |
chr2:113881000-113882000 |
Enhancers |
Duodenum Mucosa |
Duodenum
|
12 |
chr2:113881000-113882800 |
Enhancers |
Primary hematopoietic stem cells |
blood
|
13 |
chr2:113881200-113882000 |
Weak transcription |
Lung |
lung
|
14 |
chr2:113881200-113883200 |
Weak transcription |
Liver |
Liver
|
15 |
chr2:113881200-113884600 |
Enhancers |
Primary B cells from cord blood |
blood
|
16 |
chr2:113881400-113882200 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
17 |
chr2:113881400-113882400 |
Enhancers |
Foreskin Melanocyte Primary Cells skin03 |
Skin
|
18 |
chr2:113881400-113882400 |
Enhancers |
NH-A |
brain
|
19 |
chr2:113881400-113882600 |
Flanking Active TSS |
Primary neutrophils fromperipheralblood |
blood
|
20 |
chr2:113881400-113882800 |
Flanking Active TSS |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
21 |
chr2:113881400-113883200 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
22 |
chr2:113881600-113882400 |
Enhancers |
Adipose Nuclei |
Adipose
|
23 |
chr2:113881600-113882600 |
Enhancers |
Primary B cells from peripheral blood |
blood
|
24 |
chr2:113881600-113882600 |
Flanking Active TSS |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
25 |
chr2:113881600-113882800 |
Enhancers |
Fetal Heart |
heart
|
26 |
chr2:113881600-113882800 |
Enhancers |
Stomach Mucosa |
stomach
|
27 |
chr2:113881600-113883200 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
28 |
chr2:113881600-113883200 |
Enhancers |
HMEC |
breast
|
29 |
chr2:113881600-113884800 |
Enhancers |
Fetal Adrenal Gland |
Adrenal Gland
|
30 |
chr2:113881800-113882000 |
Bivalent Enhancer |
Primary T cells fromperipheralblood |
blood
|
31 |
chr2:113881800-113882000 |
Bivalent Enhancer |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
32 |
chr2:113881800-113882000 |
Bivalent Enhancer |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
33 |
chr2:113881800-113882200 |
Enhancers |
Primary T helper cells fromperipheralblood |
blood
|
34 |
chr2:113881800-113882600 |
Enhancers |
Left Ventricle |
heart
|
35 |
chr2:113881800-113882600 |
Enhancers |
Right Ventricle |
heart
|
36 |
chr2:113881800-113882600 |
Flanking Active TSS |
GM12878-XiMat |
blood
|
37 |
chr2:113881800-113882800 |
Enhancers |
NHDF-Ad |
bronchial
|
38 |
chr2:113881800-113882800 |
Flanking Active TSS |
NHEK |
skin
|
39 |
chr2:113881800-113883200 |
Enhancers |
HUVEC |
blood vessel
|
40 |
chr2:113881800-113883200 |
Bivalent Enhancer |
Osteobl |
bone
|
41 |
chr2:113881800-113883400 |
Enhancers |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|